White Paper
|
By Michael Murphy, Ph.D., Fredrik Sundberg, Ph.D., and Paul Belcher, Ph.D.,
Cytiva
Discover how SPR can be used to accelerate vaccine discovery and development by helping overcome analytical challenges that have plagued the industry for decades.
|